440 Investment Group LLC lessened its holdings in shares of Thermo Fisher Scientific Inc (NYSE:TMO) by 11.2% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 5,923 shares of the medical research company’s stock after selling 750 shares during the period. 440 Investment Group LLC’s holdings in Thermo Fisher Scientific were worth $1,033,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Proficio Capital Partners LLC grew its position in shares of Thermo Fisher Scientific by 71.5% during the 1st quarter. Proficio Capital Partners LLC now owns 607 shares of the medical research company’s stock worth $105,000 after purchasing an additional 253 shares in the last quarter. Chicago Partners Investment Group LLC acquired a new position in shares of Thermo Fisher Scientific during the 2nd quarter worth approximately $108,000. Cribstone Capital Management LLC grew its position in shares of Thermo Fisher Scientific by 8.7% during the 2nd quarter. Cribstone Capital Management LLC now owns 625 shares of the medical research company’s stock worth $109,000 after purchasing an additional 50 shares in the last quarter. Sharkey Howes & Javer grew its position in shares of Thermo Fisher Scientific by 1.0% during the 1st quarter. Sharkey Howes & Javer now owns 733 shares of the medical research company’s stock worth $113,000 after purchasing an additional 7 shares in the last quarter. Finally, Shine Investment Advisory Services Inc. acquired a new position in shares of Thermo Fisher Scientific during the 2nd quarter worth approximately $113,000. Hedge funds and other institutional investors own 83.36% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece of content on another domain, it was stolen and republished in violation of international trademark and copyright laws. The original version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/09/22/440-investment-group-llc-has-1-03-million-holdings-in-thermo-fisher-scientific-inc-tmo.html.

In other Thermo Fisher Scientific news, VP Peter E. Hornstra sold 3,894 shares of the business’s stock in a transaction that occurred on Tuesday, September 5th. The shares were sold at an average price of $185.18, for a total value of $721,090.92. Following the completion of the transaction, the vice president now owns 19,751 shares of the company’s stock, valued at approximately $3,657,490.18. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director C Martin Harris sold 360 shares of the business’s stock in a transaction that occurred on Wednesday, August 30th. The stock was sold at an average price of $180.97, for a total transaction of $65,149.20. Following the completion of the transaction, the director now directly owns 5,312 shares of the company’s stock, valued at approximately $961,312.64. The disclosure for this sale can be found here. In the last three months, insiders sold 22,738 shares of company stock valued at $4,021,512. Corporate insiders own 0.49% of the company’s stock.

A number of research analysts have issued reports on TMO shares. Deutsche Bank AG set a $200.00 target price on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a research report on Saturday, June 10th. BidaskClub lowered shares of Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, June 27th. Citigroup Inc. restated a “buy” rating and set a $201.00 target price (up previously from $182.00) on shares of Thermo Fisher Scientific in a research report on Monday, July 10th. Zacks Investment Research upgraded shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $199.00 target price on the stock in a research report on Tuesday, July 11th. Finally, Wells Fargo & Company restated an “outperform” rating and set a $200.00 target price (up previously from $195.00) on shares of Thermo Fisher Scientific in a research report on Thursday, July 13th. One research analyst has rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the company. The company currently has a consensus rating of “Buy” and an average target price of $193.44.

Thermo Fisher Scientific Inc (NYSE:TMO) opened at 187.91 on Friday. The company has a 50-day moving average of $181.07 and a 200 day moving average of $171.15. Thermo Fisher Scientific Inc has a 52 week low of $139.07 and a 52 week high of $194.30. The company has a market cap of $73.31 billion, a P/E ratio of 32.74 and a beta of 1.05.

Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings results on Wednesday, July 26th. The medical research company reported $2.30 EPS for the quarter, topping the Zacks’ consensus estimate of $2.27 by $0.03. Thermo Fisher Scientific had a net margin of 11.80% and a return on equity of 15.97%. The business had revenue of $5 billion during the quarter, compared to analysts’ expectations of $4.92 billion. During the same quarter in the previous year, the company earned $2.03 EPS. The business’s quarterly revenue was up 10.2% compared to the same quarter last year. On average, equities analysts forecast that Thermo Fisher Scientific Inc will post $9.35 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Monday, October 16th. Shareholders of record on Friday, September 15th will be paid a $0.15 dividend. The ex-dividend date is Thursday, September 14th. This represents a $0.60 dividend on an annualized basis and a yield of 0.32%. Thermo Fisher Scientific’s dividend payout ratio is presently 10.45%.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Stock Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related stocks with our FREE daily email newsletter.